AeroSafe Global appointed Rick Lozano to the CEO of the company
AeroSafe Global, a leading provider of cold chain solutions for the safe, sustainable delivery and effective use of biopharmaceuticals across the supply chain, today announced that Rick Lozano has joined the company as Chief Commercial Officer. Lozano, a seasoned pharmaceutical sales executive, brings over 20 years of experience to this new role where he drives new sales and organic accounting. Lozano is going to work closely with the CEO of AeroSafe Global, Scott Whyte, as the company continues to become competitive.
Last year, Lozano was Senior Vice President of AmerisourceBergen, one of the nation's top pharmaceutical distributors. Lozano helped drive strategic direction of the company to generate new business and renew growth. He joined AmerisourceBergen in 2012 before he was appointed Specialty Physician Services. Lozano acted in various roles with pharmaceutical manufacturers, including Dendreon Corporation, AMAG Pharmaceuticals and Johnson & Johnson.
"We are very excited to see Rick join our team. He brings to his role a wealth of industry experience and he is passionate about the work we do to protect the integrity of medicines during transit. With his talent for relationship building, proven track record of commercial results, and interest in emerging digital technologies for a green supply chain, I am sure Rick will contribute to our already impressive growth trajectory.
Lozano will work with Scott Whyte, CEO of AeroSafe Global, who joined the company in late 2020 after working in provider, payer and pharmaceutical technology. Whyte's experience spans 25 years, including senior management positions at ClearDATA, CommonSpirit and Phoenix Children'' Hospital. He is leading the development and execution of AeroSafe's next control tower platform, sustainability customer portal and digital engagement offerings.
"I am pleased to join a company with passion, innovation, and experience to make measurable difference in the lives of patients. AeroSafe is committed to fortifying the cold chain so that no inferior product reaches a patient," offered Lozano. AeroSafe's solutions provide the patient, the provider and the planet with the development of personalized medicine, rapid development and new focus on corporate ESG initiatives.
About AeroSafe Global Aerospace
AeroSafe Global helps biopharmaceutical manufacturers improve patient lives by providing safe, efficient, and effective delivery of temperature-sensitive therapeutics from pandemic vaccines to immunotherapies and medicines people use daily. The company combines innovation with patented cold chain technology, an intelligent logistic platform and focus on enhancing environmental sustainability through a re-use model, and integrating innovation into every phase of supply chain journey to be 100% secure. For more information, please visit www.aerosafeglobal.com.
Media Contact:Jennifer Crowley [email protected] 585-504-1769
SOURCE AeroSafe Global and SNORCE, Global.